Literature DB >> 22521212

Ultrasound-assisted extraction of three bufadienolides from Chinese medicine ChanSu.

Yinshi Sun1, Jianjie Bi, Li Zhang, Baoxing Ye.   

Abstract

In this study, the application of ultrasound-assisted extraction (UAE) method was shown to be more efficient in extracting anti-tumor bufadienolides (bufalin, cinobufagin and resibufogenin) from important animal medicine of ChanSu than the maceration extraction (ME) and soxhlet extraction (SE) method. The effects of ultrasonic variables including extraction solvent, solvent concentration, solvent to solid ratio, ultrasound power, temperature, extraction time and particle size on the yields of three bufadienolides were investigated. The optimum extraction conditions found were: 70% (v/v) methanol solution, solvent to solid ratio of 10ml/g, ultrasound power of 125W, temperature of 20°C, extraction time of 20min and particle size of 60-80 mesh. The extraction yields of bufalin, cinobufagin and resibufogenin were 43.17±0.85, 52.58±1.12, 137.70±2.65mg/g, respectively. In order to achieve a similar yield as UAE, soxhlet extraction required 6h and maceration extraction required much longer time of 18h. The results indicated that UAE is an alternative method for extracting bufadienolides from ChanSu.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521212     DOI: 10.1016/j.ultsonch.2012.03.003

Source DB:  PubMed          Journal:  Ultrason Sonochem        ISSN: 1350-4177            Impact factor:   7.491


  2 in total

1.  Effect of germinated brown rice extracts on pancreatic lipase, adipogenesis and lipolysis in 3T3-L1 adipocytes.

Authors:  See Meng Lim; Yong Meng Goh; Wen Bin Kuan; Su Peng Loh
Journal:  Lipids Health Dis       Date:  2014-11-03       Impact factor: 3.876

2.  Cinobufagin inhibits tumor growth by inducing apoptosis through Notch signaling pathways in human cholangiocarcinoma.

Authors:  Jiajun Ren; Shouhua Wang; Longyang Jin; Fei Ma; Di Zhou; Qiang Cai
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.